These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31256027)

  • 21. A trend in prevalence of antimicrobial use and appropriateness of antimicrobial therapy in an acute care hospital from 2018 to 2019: repeated prevalence surveys in Japan.
    Komagamine J; Yabuki T; Hiraiwa T
    BMC Res Notes; 2019 Dec; 12(1):811. PubMed ID: 31849341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011.
    Reilly JS; Price L; Godwin J; Cairns S; Hopkins S; Cookson B; Malcolm W; Hughes G; Lyytikainen O; Coignard B; Hansen S; Suetens C;
    Euro Surveill; 2015 Feb; 20(8):. PubMed ID: 25742434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Point prevalence survey of antibiotic use and healthcare-associated infections in acute care hospitals: a comprehensive report from the Marche Region of Italy.
    Barbadoro P; Dolcini J; Fortunato C; Mengarelli Detto Rinaldini D; Martini E; Gioia MG; Mengoni D; D'Errico MM;
    J Hosp Infect; 2023 Nov; 141():80-87. PubMed ID: 37574019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nationwide assessment of the burden of healthcare-associated infections and antimicrobial use among surgical patients: results from Serbian point prevalence survey, 2017.
    Šuljagić V; Bajčetić M; Mioljević V; Dragovac G; Mijović B; Janićijević I; Đorđević Z; Krtinić G; Rakić V; Ćirković I; Nikolić V; Marković-Denić L
    Antimicrob Resist Infect Control; 2021 Mar; 10(1):47. PubMed ID: 33676578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals.
    Gravel D; Taylor G; Ofner M; Johnston L; Loeb M; Roth VR; Stegenga J; Bryce E; ; Matlow A
    J Hosp Infect; 2007 Jul; 66(3):243-8. PubMed ID: 17574304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.
    Cassini A; Plachouras D; Eckmanns T; Abu Sin M; Blank HP; Ducomble T; Haller S; Harder T; Klingeberg A; Sixtensson M; Velasco E; Weiß B; Kramarz P; Monnet DL; Kretzschmar ME; Suetens C
    PLoS Med; 2016 Oct; 13(10):e1002150. PubMed ID: 27755545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 2-year point-prevalence surveillance of healthcare-associated infections and antimicrobial use in Ferrara University Hospital, Italy.
    Antonioli P; Bolognesi N; Valpiani G; Morotti C; Bernardini D; Bravi F; Di Ruscio E; Stefanati A; Gabutti G
    BMC Infect Dis; 2020 Jan; 20(1):75. PubMed ID: 31973704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Australia-wide point prevalence survey of the use and appropriateness of antimicrobial prescribing for children in hospital.
    Osowicki J; Gwee A; Noronha J; Palasanthiran P; McMullan B; Britton PN; Isaacs D; Lai T; Nourse C; Avent M; Moriarty P; Clark J; Francis JR; Blyth CC; Cooper CM; Bryant PA
    Med J Aust; 2014 Dec; 201(11):657-62. PubMed ID: 25495311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The first multi-centre point-prevalence survey in four Japanese university hospitals.
    Morioka H; Nagao M; Yoshihara S; Ohge H; Kasahara K; Shigemoto N; Kajihara T; Mori M; Iguchi M; Tomita Y; Ichiyama S; Yagi T
    J Hosp Infect; 2018 Jul; 99(3):325-331. PubMed ID: 29549049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A national point prevalence study on healthcare-associated infections and antimicrobial use in Austria.
    Segagni Lusignani L; Blacky A; Starzengruber P; Diab-Elschahawi M; Wrba T; Presterl E
    Wien Klin Wochenschr; 2016 Feb; 128(3-4):89-94. PubMed ID: 26817781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence survey of healthcare-associated infections and antimicrobial use at the University Hospital "Paolo Giaccone", Palermo, Italy.
    Sinatra I; Carubia L; Marchese V; Aprea L; D'Alessandro N; Mammina C; Torregrossa MV
    J Prev Med Hyg; 2013 Dec; 54(4):200-4. PubMed ID: 24779280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antimicrobial use and healthcare-associated infections in China: Results from the first point prevalence survey in 18 hospitals in Shanxi Province.
    Li X; Cai W; Song Y; Kang J; Ji X; Tian F; Yin D; Wang S; Guo Q; Song J; Shi N; Duan J
    J Glob Antimicrob Resist; 2023 Jun; 33():283-290. PubMed ID: 37100239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial use, healthcare-associated infections, and bacterial resistance in general hospitals in China: the first national pilot point prevalence survey report.
    Xiao Y; Xin X; Chen Y; Yan Q;
    Eur J Clin Microbiol Infect Dis; 2023 Jun; 42(6):715-726. PubMed ID: 37067662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-day point prevalence of healthcare-associated infections and antimicrobial use in four countries in Latin America.
    Huerta-Gutiérrez R; Braga L; Camacho-Ortiz A; Díaz-Ponce H; García-Mollinedo L; Guzmán-Blanco M; Valderrama-Beltrán S; Landaeta-Nezer E; Moreno-Espinosa S; Morfín-Otero R; Rodríguez-Zulueta P; Rosado-Buzzo A; Rosso-Suárez F; Trindade-Clemente W; Wiltgen D
    Int J Infect Dis; 2019 Sep; 86():157-166. PubMed ID: 31229613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Point prevalence and risk factors of hospital acquired infections in a cluster of university-affiliated hospitals in Shiraz, Iran.
    Askarian M; Yadollahi M; Assadian O
    J Infect Public Health; 2012 Apr; 5(2):169-76. PubMed ID: 22541264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Point prevalence survey of healthcare-associated infections and use of antimicrobials in Irish intellectual disability long-term care facilities: 2013.
    Roche FM; Donlon S; Burns K
    J Hosp Infect; 2016 Aug; 93(4):410-7. PubMed ID: 27112050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point prevalence surveys of healthcare-associated infections and use of indwelling devices and antimicrobials over three years in a tertiary care hospital in India.
    Kumar A; Biswal M; Dhaliwal N; Mahesh R; Appannanavar SB; Gautam V; Ray P; Gupta AK; Taneja N
    J Hosp Infect; 2014 Apr; 86(4):272-4. PubMed ID: 24613563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence study on health-care associated infections and on the use of antimicrobials carried out with the light protocol of the European Centre for Disease Prevention and Control.
    Gugliotta C; Deiana G; Dettori M; Sotgiu G; Azara A; Castiglia P
    Ann Ig; 2020; 32(4):357-367. PubMed ID: 32744294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. THE GLOBAL POINT PREVALENCE SURVEY (PPS) OF ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE AMONG HOSPITALIZED CHILDREN IN GEORGIA.
    Korinteli IG; Mchedlishvili I; Javakhadze M; Versporten A; Goossens H; Phagava H; Pagava K
    Georgian Med News; 2019; (292-293):72-75. PubMed ID: 31560667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PAUSATE Study: Prevalence and appropriateness of the use of antimicrobials in Spanish hospitals.
    Gutiérrez-Urbón JM; Arenere-Mendoza M; Fernández-de-Gamarra-Martínez E; Fernández-Polo A; González-Suárez S; Nicolás-Picó J; Rodríguez-Mateos ME; Sánchez-Yáñez E
    Farm Hosp; 2022 Aug; 46(5):271-281. PubMed ID: 36183227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.